Contact details

Jack Digby

T: +44 20 7809 2265 M: +44 7557 740 397 Email Jack | vCard Office: London

Jack Digby Associate

Contact details

Jack Digby

Jack Digby

T: +44 20 7809 2265 M: +44 7557 740 397 Email Jack | vCard Office: London

Jack is an associate in our funds and equity capital markets team, specialising in public company IPOs, secondary issues, mergers and acquisitions, joint ventures and corporate advisory matters.
  • Profile
  • Services

Jack has experience advising clients on a variety of corporate finance transactions, including public company IPOs and secondary issues (both issuer and bank-side), private and public company acquisitions, fundraisings, joint ventures, corporate restructures and general company law issues.

Jack has worked with both UK, Australian and international clients across a range of sectors, including mining and exploration, healthcare, technology and natural resources.

Prior to joining Stephenson Harwood, Jack worked in the Sydney office of an international firm advising on capital raisings and general corporate transactions.

  • Equity capital markets
  • Public and private M&A

GLI Finance Limited

Advised long-standing client GLI Finance Limited on a complex fundraising and restructuring. GLI is a specialist provider of alternative finance to SMEs. 

Acacia Pharma Group plc

Advised long-standing client Acacia Pharma as issuer's UK counsel on all aspects of its €27 million fundraising. 

Shield Therapeutics plc

Acted for Shield Therapeutics plc on its placing and the subscription raising aggregate gross proceeds of up to £25.0 million for the Company (approximately £23.6 million net of expenses), and an open offer to be made to shareholders to raise up to an additional £4.2 million.

finnCap Ltd

Advised finnCap Ltd as nominated adviser and broker to Access Intelligence plc and its £10 million placing. 

NetScientific plc

Advised NetScientific on acquisition of EMV Capital, Rule 9 waiver in respect of the consideration shares and related placing.

Landore Resources Limited

Advised Landore Resources Limited in relation to subscriptions undertaken in January 2020, April 2020, June 2020 (£2,800,000) and February 2021 (£3.5 million).  

Acacia Pharma Group plc

Advised Acacia Pharma on its €25 million equity fundraising on Euronext Brussels. The net proceeds of the placing were intended for: (i) the recruitment of an initial sales force and support staff; (ii) payment of marketing costs relating to Acacia's lead products BARHEMSYS® and BYFAVO™; (iii) implementation of post-approval research and development commitments for BARHEMSYS® and BYFAVO™; and (iv) satisfaction of interest and capital payments under Acacia's existing loan agreements.

Riverfort Global Opportunities PCC Limited

Advised Riverfort Global Opportunities PCC Limited and related parties on various convertible loan instruments with AIM listed companies, including Premier African Minerals Limited. 

Australian IPOs and secondary raisings

Worked on numerous IPOs and secondary raisings as a lawyer in Australia prior to joining Stephenson Harwood.

Nexus Group/Harry Hyman

Advised the Nexus Group on Primary Health Properties plc's £33.1 million acquisition of Nexus Tradeco Holdings Ltd.

NetScientific plc

Advised NetScientific plc on its acquisition of EMV Capital Limited.

Acquisition of water company

Advised Australian PE Firm on acquisition of a water and hydraulics company.

Acquisition of education business

Advised international investment and advisory firm on acquisition and subsequent sale of education business in Australia.

More: Public and private M&A

Latest news & insights

22 Jul 2021

From News

Stephenson Harwood advises on Microlise IPO

Law firm Stephenson Harwood LLP has advised Singer Capital Markets Advisory LLP in its role as nominated advisor, sole broker and bookrunner to Microlise on Microlise’..


22 Jun 2021

From News

Stephenson Harwood advises finnCap on Access Intelligence deal

Law firm Stephenson Harwood LLP has advised finnCap, in its role as nominated advisor and broker, on Access Intelligence PLC’s £19.4 million acquisition of Isentia Gro..


23 Feb 2021

From News

Stephenson Harwood advises Acacia Pharma on €27 million fundraise

Law firm Stephenson Harwood LLP has advised Acacia Pharma Group plc on its successful €27 million fundraise, through the placing of 10 million new ordinary shares with..


© Stephenson Harwood LLP 2016. Any reference to Stephenson Harwood in this document means Stephenson Harwood LLP and/or its affiliated undertakings. Any reference to a partner is used to refer to a member of Stephenson Harwood LLP.